Loading company…
ImmunoMolecular Therapeutics, Inc.
PrivateWon a federal SBIR/STTR research award from HHS and other federal agencies.
Department of Health and Human ServicesNational Institutes of Health
- SAM UEI
- LD87RRTVMGM1
- Founded
- —Source: [GOV]
- Headquarters
- Aurora, ColoradoSource: [GOV]
- Headcount
- 3Source: [GOV]
- Stage
- Seed
- Sector
- Healthcare
$0Source: [GOV]Total raised
UndisclosedSource: [GOV]Last valuation
Overview
ImmunoMolecular Therapeutics, Inc. has been awarded 1 US Small Business Innovation Research (SBIR/STTR) contract totalling $224,991 in 2018. These are non-dilutive federal research grants, not equity financing. The company is based in Aurora, Colorado.
Funding rounds
1 rounds- SBIR Phase I award (HHS)GrantSep 2018Source: [GOV]$225K—post-money
Investors
No investors recorded yet for ImmunoMolecular Therapeutics, Inc..
Add an investorPeople
LeadershipAcquisitions
ImmunoMolecular Therapeutics, Inc. has no recorded acquisitions.
Add an acquisitionExits
Still private — no exit on record.
Record an exitDiversity investments
No diversity signals recorded yet for ImmunoMolecular Therapeutics, Inc..
Add diversity data